Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03500757 · ClinicalTrials.gov registry record
Intra-procedural 360-degree Display for Performing Percutaneous Liver Tumor Ablation
A clinical trial, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- 11
- Enrollment target
NCT03500757: Completed study, sponsored by Case Comprehensive Cancer Center.
NCT03500757 is a clinical trial that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03500757 has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
Study Summary
Medical images used to guide treatment of tumor(s) are presently displayed on flat-panel monitors (like screens used with computers). This protocol will evaluate, using a new headset to view the images in true 3D ("360 degrees"), while using standard flat panel monitors as usual (in accordance with standard of care). The headset is combined with a mini-global positioning system (GPS)-like system to help navigate to treat tumor(s). This evaluation is to show that the headset has potential to provide guidance and navigation information that can improve the treatment of tumor(s) with heat.
Primary Outcome
The surgeons and staff completing the intervention will rate the usability of the system. An average score greater than 3 will indicate acceptability of the 360 degree display.
Interventions
- DEVICE HoloLens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2018-04-29 |
| Est. Completion | 2022-05-16 |
What the finished NCT03500757 record still lists
NCT03500757 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which HoloLens is the first listed.
NCT03500757 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03500757 about?
NCT03500757 is a clinical study titled "Intra-procedural 360-degree Display for Performing Percutaneous Liver Tumor Ablation". Medical images used to guide treatment of tumor(s) are presently displayed on flat-panel monitors (like screens used with computers). This protocol will evaluate, using a new headset to view the images in true 3D ("360 degrees"), while using standard flat panel monitors as usual (in accordance with ...
What is the current status of trial NCT03500757?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2018-04-29. Estimated completion is 2022-05-16.
What interventions are being tested in trial NCT03500757?
The interventions under investigation include: HoloLens (DEVICE).
Who is sponsoring clinical trial NCT03500757?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI